catalog number :
MBS605436
products full name :
Ras, pan, N,H,K
products short name :
Ras, pan, N,H,K
products name syn :
Anti -Ras, pan, N,H,K
other names :
Ras oncogene at 85D; CG9375 gene product from transcript CG9375-RA; CG9375-PA; Ras GTPase; Ras oncogene at 85B; Ras oncogene at 85D; Ras1; Ras85D-PA; enhancer of faf; Ras oncogene at 85D
other gene names :
Ras85D; C-ras1; CG9375; D-Ras; D-ras-1; D-ras1; D-Ras1; Dm Ras1; DmelCG9375; Dmras85D; dRas; Dras; DRas; dras1; dRas1; dRAS1; Dras1; DRAS1; dRas85D; Dras85D; DRas85D/Ras; E(faf); E(sev)3C; EK3-4; fs(3)05703; l(3)06677; l(3)s1747; p21[Ras1]; ras; Ras; RAS; ras 1;
reactivity :
Drosophila, Human, Monkey, Mouse, Rat, Yeast
specificity :
Recognizes endogenous levels of human total K-Ras, H-Ras and N-Ras proteins at ~21kD. Species Crossreactivity mouse, monkey, rat, Drosophila, S. cerevisiae.
purity :
Supernatant. Supernatant
form :
Supplied as a liquid in 10mM sodium HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, <0.02% sodium azide, 50% glycerol.
storage stability :
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
tested application :
ELISA (EL/EIA), Western Blot (WB)
app notes :
Suitable for use in ELISA and Western Blot. Dilution: Western Blot: 1:1000
other info1 :
Immunogen: Synthetic peptide corresponding to residues near the amino terminus of human K-Ras (KLH).
products categories :
Antibodies; Abs to Cancer Markers
products description :
The 21kD guanine-nucleotide binding proteins (K-Ras, H-Ras and N-Ras) cycle between active (GTP-bound) and inactive (GDP-bound) forms. Receptor tyrosine kinases and G-protein-coupled receptors activate Ras, which then stimulates the Raf-MEK-MAPK pathway. GTPase-activating proteins (GAP) normally facilitate the inactivation of Ras. However, in 30% of human tumors, point mutations in Ras prevent the GAP-mediated inhibition of this pathway. The most common oncogenic Ras mutation found in tumors is Gly12 to Asp (G12D), which prevents Ras inactivation, possibly by increasing the overall rigidity of the protein.
ncbi acc num :
NP_476699.1
ncbi gb acc num :
NM_057351.5
ncbi pathways :
ARMS-mediated Activation Pathway (824068); Axon Guidance Pathway (824307); Cytokine Signaling In Immune System Pathway (824551); DAP12 Interactions Pathway (824545); DAP12 Signaling Pathway (824546); Developmental Biology Pathway (824306); Disease Pathway (823917); Dorso-ventral Axis Formation Pathway (3095); Dorso-ventral Axis Formation Pathway (472); Downstream Signal Transduction Pathway (824077)